Literature DB >> 9124415

Phospholamban deficiency alters inactivation kinetics of L-type Ca2+ channels in mouse ventricular myocytes.

H Masaki1, Y Sato, W Luo, E G Kranias, A Yatani.   

Abstract

Entry of Ca2+ through voltage-dependent L-type Ca2+ channels is critical for contraction in cardiac cells. In recent studies, cells from phospholamban (PLB) knockout (PLB-KO) mouse hearts showed significantly increased basal contractility with enhanced sarcoplasmic reticulum (SR) Ca2+ uptake. To test whether these effects of PLB ablation were associated with alterations of L-type Ca2+ channel function, we compared the properties of Ca2+ channel currents (I(Ca)) in ventricular myocytes isolated from wild-type (WT) and PLB-KO mouse hearts. L-type Ca2+ channels from mouse myocytes exhibited voltage-dependent gating and sensitivity to dihydropyridine drugs, similar to other mammalian species, and these properties were not altered by PLB ablation. I(Ca) from both WT and PLB-KO cells revealed two (fast and slow) components of inactivation kinetics. However, the proportion of the faster component was significantly larger in PLB-KO cells. Ryanodine (10 microM) reduced the rate of inactivation of I(Ca) for both WT and PLB-KO cells, but the reduction was more prominent in PLB-KO cells compared with WT cells. In contrast, the inactivation in a Ba2+ solution could be fitted by a single exponential similar to the slower component in Ca2+, and this was not altered in PLB-KO cells. The increase in the fast Ca2+-dependent inactivation component in PLB-KO cells supports the hypothesis that Ca2+ released from the SR regulates Ca2+ channel inactivation by affecting the levels of Ca2+ near the channel and suggests that this may be an important compensatory mechanism in the hyperdynamic PLB-KO heart.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9124415     DOI: 10.1152/ajpheart.1997.272.2.H606

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  16 in total

1.  Type 1 phosphatase, a negative regulator of cardiac function.

Authors:  Andrew N Carr; Albrecht G Schmidt; Yoichi Suzuki; Federica del Monte; Yoji Sato; Carita Lanner; Kristine Breeden; Shao-Ling Jing; Patrick B Allen; Paul Greengard; Atsuko Yatani; Brian D Hoit; Ingrid L Grupp; Roger J Hajjar; Anna A DePaoli-Roach; Evangelia G Kranias
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

2.  Enhanced L-type calcium currents in cardiomyocytes from transgenic rats overexpressing SERCA2a.

Authors:  Andre Kamkin; Irina Kiseleva; Heinz Theres; Jaime-Jürgen Eulert-Grehn; Kay-Dietrich Wagner; Holger Scholz; Roland Vetter
Journal:  Exp Clin Cardiol       Date:  2010

3.  Transmural heterogeneity of repolarization and Ca2+ handling in a model of mouse ventricular tissue.

Authors:  Vladimir E Bondarenko; Randall L Rasmusson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-06-04       Impact factor: 4.733

4.  Cardiac-specific overexpression of AT1 receptor mutant lacking G alpha q/G alpha i coupling causes hypertrophy and bradycardia in transgenic mice.

Authors:  Peiyong Zhai; Mitsutaka Yamamoto; Jonathan Galeotti; Jing Liu; Malthi Masurekar; Jill Thaisz; Keiichi Irie; Eric Holle; Xianzhong Yu; Sabina Kupershmidt; Dan M Roden; Thomas Wagner; Atsuko Yatani; Dorothy E Vatner; Stephen F Vatner; Junichi Sadoshima
Journal:  J Clin Invest       Date:  2005-11       Impact factor: 14.808

5.  Differential regulation of inotropy and lusitropy in overexpressed Gsalpha myocytes through cAMP and Ca2+ channel pathways.

Authors:  S J Kim; A Yatani; D E Vatner; S Yamamoto; Y Ishikawa; T E Wagner; R P Shannon; Y K Kim; G Takagi; K Asai; C J Homcy; S F Vatner
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

6.  Ablation of phospholamban and sarcolipin results in cardiac hypertrophy and decreased cardiac contractility.

Authors:  Mayilvahanan Shanmugam; Shumin Gao; Chull Hong; Nadezhda Fefelova; Martha C Nowycky; Lai-Hua Xie; Muthu Periasamy; Gopal J Babu
Journal:  Cardiovasc Res       Date:  2010-09-10       Impact factor: 10.787

7.  Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects.

Authors:  H Masaki; T Kurihara; A Yamaki; N Inomata; Y Nozawa; Y Mori; S Murasawa; K Kizima; K Maruyama; M Horiuchi; V J Dzau; H Takahashi; T Iwasaka; M Inada; H Matsubara
Journal:  J Clin Invest       Date:  1998-02-01       Impact factor: 14.808

8.  Activation of Mst1 causes dilated cardiomyopathy by stimulating apoptosis without compensatory ventricular myocyte hypertrophy.

Authors:  Shimako Yamamoto; Guiping Yang; Daniela Zablocki; Jing Liu; Chull Hong; Song-Jung Kim; Sandra Soler; Mari Odashima; Jill Thaisz; Ghassan Yehia; Carlos A Molina; Atsuko Yatani; Dorothy E Vatner; Stephen F Vatner; Junichi Sadoshima
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

Review 9.  Novel mechanisms mediating stunned myocardium.

Authors:  Song-Jung Kim; Christophe Depre; Stephen F Vatner
Journal:  Heart Fail Rev       Date:  2003-04       Impact factor: 4.214

10.  Regulation of excitation-contraction coupling in mouse cardiac myocytes: integrative analysis with mathematical modelling.

Authors:  Jussi T Koivumäki; Topi Korhonen; Jouni Takalo; Matti Weckström; Pasi Tavi
Journal:  BMC Physiol       Date:  2009-08-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.